6.
de Leon U, Vazquez-Jimenez A, Matadamas-Guzman M, Pelayo R, Resendis-Antonio O
. Transcriptional and Microenvironmental Landscape of Macrophage Transition in Cancer: A Boolean Analysis. Front Immunol. 2021; 12:642842.
PMC: 8222808.
DOI: 10.3389/fimmu.2021.642842.
View
7.
Selig M, Poehlman L, Lang N, Volker M, Rolauffs B, Hart M
. Prediction of six macrophage phenotypes and their IL-10 content based on single-cell morphology using artificial intelligence. Front Immunol. 2024; 14:1336393.
PMC: 10794337.
DOI: 10.3389/fimmu.2023.1336393.
View
8.
Malyshev I, Malyshev Y
. Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage "Switch" Phenotype. Biomed Res Int. 2015; 2015:341308.
PMC: 4561113.
DOI: 10.1155/2015/341308.
View
9.
Ruffell B, Affara N, Coussens L
. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012; 33(3):119-26.
PMC: 3294003.
DOI: 10.1016/j.it.2011.12.001.
View
10.
Kratochvill F, Neale G, Haverkamp J, Van de Velde L, Smith A, Kawauchi D
. TNF Counterbalances the Emergence of M2 Tumor Macrophages. Cell Rep. 2015; 12(11):1902-14.
PMC: 4581986.
DOI: 10.1016/j.celrep.2015.08.033.
View
11.
Piersma B, Hayward M, Weaver V
. Fibrosis and cancer: A strained relationship. Biochim Biophys Acta Rev Cancer. 2020; 1873(2):188356.
PMC: 7733542.
DOI: 10.1016/j.bbcan.2020.188356.
View
12.
Bally A, Lu P, Tang Y, Austin J, Scharer C, Ahmed R
. NF-κB regulates PD-1 expression in macrophages. J Immunol. 2015; 194(9):4545-54.
PMC: 4402259.
DOI: 10.4049/jimmunol.1402550.
View
13.
Wang L, Zhang S, Wu H, Rong X, Guo J
. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 2018; 106(2):345-358.
PMC: 7379745.
DOI: 10.1002/JLB.3RU1018-378RR.
View
14.
Ohama H, Asai A, Ito I, Suzuki S, Kobayashi M, Higuchi K
. M2b macrophage elimination and improved resistance of mice with chronic alcohol consumption to opportunistic infections. Am J Pathol. 2014; 185(2):420-31.
DOI: 10.1016/j.ajpath.2014.09.022.
View
15.
Wang H, Wang L, Chi P, Wang W, Chen X, Geng Q
. High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma. Br J Cancer. 2016; 114(4):463-8.
PMC: 4815778.
DOI: 10.1038/bjc.2016.11.
View
16.
Zhao S, Wu D, Wu P, Wang Z, Huang J
. Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLoS One. 2015; 10(10):e0139598.
PMC: 4595202.
DOI: 10.1371/journal.pone.0139598.
View
17.
Hutchins A, Diez D, Miranda-Saavedra D
. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics. 2013; 12(6):489-98.
PMC: 3838198.
DOI: 10.1093/bfgp/elt028.
View
18.
Anders C, Lawton T, Smith H, Garret J, Doucette M, Ammons M
. Use of integrated metabolomics, transcriptomics, and signal protein profile to characterize the effector function and associated metabotype of polarized macrophage phenotypes. J Leukoc Biol. 2021; 111(3):667-693.
PMC: 8825884.
DOI: 10.1002/JLB.6A1120-744R.
View
19.
Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E
. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer. 2009; 125(2):367-73.
DOI: 10.1002/ijc.24401.
View
20.
Cui M, Huang J, Zhang S, Liu Q, Liao Q, Qiu X
. Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis. Front Immunol. 2021; 12:613530.
PMC: 8024581.
DOI: 10.3389/fimmu.2021.613530.
View